| Financial Year |
March 31 2023 |
| Monetary Funds |
17,797,675,205.72 |
| Held-for-trading Financial Assets |
709,324,940.19 |
| Notes Receivable |
243,915,556.72 |
| Accounts Receivable |
24,009,371,956.35 |
| Advances to Suppliers |
22,254,101,539.46 |
| Other Receivables |
3,806,016,576.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,718,169,540.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
436,262,475.54 |
| Other Current Assets |
3,609,366,769.86 |
| Total Current Assets |
120,466,556,996.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,000,000.00 |
| Long-term Equity Investment |
1,396,184,541.18 |
| Investment Properties |
1,045,157,045.11 |
| Fixed Assetes |
10,253,030,748.01 |
| Under-construction Projects |
178,596,544.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,115,455,147.81 |
| R&D expenses |
11,713,416.28 |
| Goodwill |
12,669,186.90 |
| Long-Term Deferred and Prepaid Expenses |
152,525,921.05 |
| Deferred Income Tax Assets |
1,523,891,266.02 |
| Other Non-Current Assets |
515,686,208.72 |
| Sub-Total of Non-Current Assets |
18,041,225,597.43 |
| Total Assets |
138,507,782,593.92 |
| Short-Term Loans |
35,498,086,404.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,633,223,374.48 |
| Accounts Payable |
13,140,250,395.79 |
| Accounts Received In Advance |
20,584,873.15 |
| Employee Compensation Payable |
1,034,712,451.27 |
| Taxes Payable |
749,955,994.35 |
| Interest Payable |
-- |
| Dividend Payable |
432,677,068.20 |
| Other payables |
2,229,846,677.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,466,830,939.20 |
| Other Current Liabilities |
11,650,726,326.69 |
| Sub-Total of Current Liabilities |
97,054,703,514.00 |
| Long-term Loans |
3,116,209,062.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,070,566.59 |
| Deferred Income Tax Liabilities |
235,050,674.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,719,728,918.57 |
| Total Liabilities |
101,774,432,432.57 |
| Paid-In Capital(Or Share Stock) |
2,263,760,805.00 |
| Capital Surplus |
6,148,283,197.05 |
| Surplus Reserve |
690,741,981.76 |
| LESS:Treasury Stock |
434,311,028.48 |
| Undistributed Profits |
6,600,239,829.47 |
| Minority Stockholder's Interest |
19,363,729,015.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,369,621,146.33 |
| Owner's Equity（Stockholder's Equity） |
36,733,350,161.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
138,507,782,593.92 |
